1. Home
  2. BLCO vs MBGL Comparison

BLCO vs MBGL Comparison

Compare BLCO & MBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.36

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Logo Mobility Global Inc. Common Stock

MBGL

Mobility Global Inc. Common Stock

HOLD

Current Price

$19.28

Market Cap

5.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLCO
MBGL
Founded
1853
2025
Country
Canada
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.9B
IPO Year
2022
2025

Fundamental Metrics

Financial Performance
Metric
BLCO
MBGL
Price
$17.36
$19.28
Analyst Decision
Buy
Buy
Analyst Count
15
12
Target Price
$19.39
★ $23.58
AVG Volume (30 Days)
482.6K
★ 3.5M
Earning Date
10-28-2026
11-12-2026
Dividend Yield
N/A
★ 1.30%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.37
Revenue
★ $5,101,000,000.00
N/A
Revenue This Year
$7.68
$7.22
Revenue Next Year
$5.95
$7.79
P/E Ratio
★ N/A
$50.19
Revenue Growth
★ 6.47
N/A
52 Week Low
$14.44
$16.95
52 Week High
$18.92
$22.33

Technical Indicators

Market Signals
Indicator
BLCO
MBGL
Relative Strength Index (RSI) 56.53 58.73
Support Level $16.71 $18.68
Resistance Level $17.54 $21.02
Average True Range (ATR) 0.52 0.53
MACD 0.07 0.20
Stochastic Oscillator 93.10 100.00

Price Performance

Historical Comparison
BLCO
MBGL

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About MBGL Mobility Global Inc. Common Stock

Mobility Global, which spun out of S&P Global on July 1, 2026, is a market-leading provider of automotive data, analytics, and software. Mobility Global consists of two segments: Carfax and B2B. Carfax is the firm's largest segment by both revenues and profits and is the market leader in the vehicle history reports, or VHR, space. The B2B segment provides auto manufacturers (original equipment manufacturers, or OEMs), auto suppliers, dealers, and others with a range of marketing, sales, strategy, and planning solutions. In 2025, Mobility Global generated 83% of its revenue in the US.

Share on Social Networks: